Report Detail

Request for Sample of this report

Chemical & Material Global Nicotinamide Mononucleotide (NMN) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM3851052
    • |
  • 25 July, 2023
    • |
  • Global
    • |
  • 93 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Chemical & Material

According to our (Global Info Research) latest study, the global Nicotinamide Mononucleotide (NMN) market size was valued at USD 306.1 million in 2022 and is forecast to a readjusted size of USD 679.1 million by 2029 with a CAGR of 12.1% during review period.
Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.
Global key players of Nicotinamide Mononucleotide (NMN) include GeneHarbor, Mirailab Bioscience, EffePharm, Herbalmax and Genex Formulas. Asia-Pacific is the largest producer, holds a share over 60%, followed by North America and Europe. In terms of product type, content greater than or equal to 98% is the largest segment, with a share over 99%. And in terms of application, the largest segment is Health Care Products, with a share over 99%.
The Global Info Research report includes an overview of the development of the Nicotinamide Mononucleotide (NMN) industry chain, the market status of Health Care Products (Content Greater than or Equal to 98%, Content Less than 98%), Cosmetics (Content Greater than or Equal to 98%, Content Less than 98%), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Nicotinamide Mononucleotide (NMN).
Regionally, the report analyzes the Nicotinamide Mononucleotide (NMN) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Nicotinamide Mononucleotide (NMN) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Nicotinamide Mononucleotide (NMN) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Nicotinamide Mononucleotide (NMN) industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Kg), revenue generated, and market share of different by Type (e.g., Content Greater than or Equal to 98%, Content Less than 98%).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Nicotinamide Mononucleotide (NMN) market.
Regional Analysis: The report involves examining the Nicotinamide Mononucleotide (NMN) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Nicotinamide Mononucleotide (NMN) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Nicotinamide Mononucleotide (NMN):
Company Analysis: Report covers individual Nicotinamide Mononucleotide (NMN) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Nicotinamide Mononucleotide (NMN) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Health Care Products, Cosmetics).
Technology Analysis: Report covers specific technologies relevant to Nicotinamide Mononucleotide (NMN). It assesses the current state, advancements, and potential future developments in Nicotinamide Mononucleotide (NMN) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Nicotinamide Mononucleotide (NMN) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Nicotinamide Mononucleotide (NMN) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Content Greater than or Equal to 98%
Content Less than 98%
Market segment by Application
Health Care Products
Cosmetics
Others
Major players covered
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nicotinamide Mononucleotide (NMN) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Nicotinamide Mononucleotide (NMN), with price, sales, revenue and global market share of Nicotinamide Mononucleotide (NMN) from 2018 to 2023.
Chapter 3, the Nicotinamide Mononucleotide (NMN) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nicotinamide Mononucleotide (NMN) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Nicotinamide Mononucleotide (NMN) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Nicotinamide Mononucleotide (NMN).
Chapter 14 and 15, to describe Nicotinamide Mononucleotide (NMN) sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Nicotinamide Mononucleotide (NMN)
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Nicotinamide Mononucleotide (NMN) Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Content Greater than or Equal to 98%
    • 1.3.3 Content Less than 98%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Nicotinamide Mononucleotide (NMN) Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Health Care Products
    • 1.4.3 Cosmetics
    • 1.4.4 Others
  • 1.5 Global Nicotinamide Mononucleotide (NMN) Market Size & Forecast
    • 1.5.1 Global Nicotinamide Mononucleotide (NMN) Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Nicotinamide Mononucleotide (NMN) Sales Quantity (2018-2029)
    • 1.5.3 Global Nicotinamide Mononucleotide (NMN) Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 GeneHarbor
    • 2.1.1 GeneHarbor Details
    • 2.1.2 GeneHarbor Major Business
    • 2.1.3 GeneHarbor Nicotinamide Mononucleotide (NMN) Product and Services
    • 2.1.4 GeneHarbor Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 GeneHarbor Recent Developments/Updates
  • 2.2 Herbalmax
    • 2.2.1 Herbalmax Details
    • 2.2.2 Herbalmax Major Business
    • 2.2.3 Herbalmax Nicotinamide Mononucleotide (NMN) Product and Services
    • 2.2.4 Herbalmax Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Herbalmax Recent Developments/Updates
  • 2.3 Genex Formulas
    • 2.3.1 Genex Formulas Details
    • 2.3.2 Genex Formulas Major Business
    • 2.3.3 Genex Formulas Nicotinamide Mononucleotide (NMN) Product and Services
    • 2.3.4 Genex Formulas Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Genex Formulas Recent Developments/Updates
  • 2.4 Shinkowa Pharmaceutical
    • 2.4.1 Shinkowa Pharmaceutical Details
    • 2.4.2 Shinkowa Pharmaceutical Major Business
    • 2.4.3 Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Product and Services
    • 2.4.4 Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Shinkowa Pharmaceutical Recent Developments/Updates
  • 2.5 Maac10 Formulas
    • 2.5.1 Maac10 Formulas Details
    • 2.5.2 Maac10 Formulas Major Business
    • 2.5.3 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Product and Services
    • 2.5.4 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Maac10 Formulas Recent Developments/Updates
  • 2.6 EffePharm
    • 2.6.1 EffePharm Details
    • 2.6.2 EffePharm Major Business
    • 2.6.3 EffePharm Nicotinamide Mononucleotide (NMN) Product and Services
    • 2.6.4 EffePharm Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 EffePharm Recent Developments/Updates
  • 2.7 Bontac
    • 2.7.1 Bontac Details
    • 2.7.2 Bontac Major Business
    • 2.7.3 Bontac Nicotinamide Mononucleotide (NMN) Product and Services
    • 2.7.4 Bontac Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Bontac Recent Developments/Updates
  • 2.8 CELFULL
    • 2.8.1 CELFULL Details
    • 2.8.2 CELFULL Major Business
    • 2.8.3 CELFULL Nicotinamide Mononucleotide (NMN) Product and Services
    • 2.8.4 CELFULL Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 CELFULL Recent Developments/Updates
  • 2.9 Kingdomway
    • 2.9.1 Kingdomway Details
    • 2.9.2 Kingdomway Major Business
    • 2.9.3 Kingdomway Nicotinamide Mononucleotide (NMN) Product and Services
    • 2.9.4 Kingdomway Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Kingdomway Recent Developments/Updates

3 Competitive Environment: Nicotinamide Mononucleotide (NMN) by Manufacturer

  • 3.1 Global Nicotinamide Mononucleotide (NMN) Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Nicotinamide Mononucleotide (NMN) Revenue by Manufacturer (2018-2023)
  • 3.3 Global Nicotinamide Mononucleotide (NMN) Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Nicotinamide Mononucleotide (NMN) by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2022
  • 3.5 Nicotinamide Mononucleotide (NMN) Market: Overall Company Footprint Analysis
    • 3.5.1 Nicotinamide Mononucleotide (NMN) Market: Region Footprint
    • 3.5.2 Nicotinamide Mononucleotide (NMN) Market: Company Product Type Footprint
    • 3.5.3 Nicotinamide Mononucleotide (NMN) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Nicotinamide Mononucleotide (NMN) Market Size by Region
    • 4.1.1 Global Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2018-2029)
    • 4.1.3 Global Nicotinamide Mononucleotide (NMN) Average Price by Region (2018-2029)
  • 4.2 North America Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
  • 4.3 Europe Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
  • 4.5 South America Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
  • 5.2 Global Nicotinamide Mononucleotide (NMN) Consumption Value by Type (2018-2029)
  • 5.3 Global Nicotinamide Mononucleotide (NMN) Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
  • 6.2 Global Nicotinamide Mononucleotide (NMN) Consumption Value by Application (2018-2029)
  • 6.3 Global Nicotinamide Mononucleotide (NMN) Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
  • 7.2 North America Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
  • 7.3 North America Nicotinamide Mononucleotide (NMN) Market Size by Country
    • 7.3.1 North America Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
  • 8.2 Europe Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
  • 8.3 Europe Nicotinamide Mononucleotide (NMN) Market Size by Country
    • 8.3.1 Europe Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Nicotinamide Mononucleotide (NMN) Market Size by Region
    • 9.3.1 Asia-Pacific Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
  • 10.2 South America Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
  • 10.3 South America Nicotinamide Mononucleotide (NMN) Market Size by Country
    • 10.3.1 South America Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Nicotinamide Mononucleotide (NMN) Market Size by Country
    • 11.3.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Nicotinamide Mononucleotide (NMN) Market Drivers
  • 12.2 Nicotinamide Mononucleotide (NMN) Market Restraints
  • 12.3 Nicotinamide Mononucleotide (NMN) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Nicotinamide Mononucleotide (NMN) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Nicotinamide Mononucleotide (NMN)
  • 13.3 Nicotinamide Mononucleotide (NMN) Production Process
  • 13.4 Nicotinamide Mononucleotide (NMN) Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Nicotinamide Mononucleotide (NMN) Typical Distributors
  • 14.3 Nicotinamide Mononucleotide (NMN) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Nicotinamide Mononucleotide (NMN). Industry analysis & Market Report on Nicotinamide Mononucleotide (NMN) is a syndicated market report, published as Global Nicotinamide Mononucleotide (NMN) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Nicotinamide Mononucleotide (NMN) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,784.00
    		4,176.00
    		5,568.00
    		3,239.88
    		4,859.82
    		6,479.76
    		540,826.80
    		811,240.20
    		1,081,653.60
    		290,580.00
    		435,870.00
    		581,160.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo